Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 968.3 Million USD | 20.48% |
| 2022 | 803.7 Million USD | 13.18% |
| 2021 | 710.1 Million USD | 2.57% |
| 2020 | 692.3 Million USD | 19.94% |
| 2019 | 577.2 Million USD | 13.27% |
| 2018 | 509.6 Million USD | 4.81% |
| 2017 | 486.2 Million USD | 10.4% |
| 2016 | 440.4 Million USD | 4.36% |
| 2015 | 422 Million USD | -11.6% |
| 2014 | 477.4 Million USD | -19.06% |
| 2013 | 589.8 Million USD | -3.55% |
| 2012 | 611.5 Million USD | 6.13% |
| 2011 | 576.2 Million USD | 12.76% |
| 2010 | 511 Million USD | 20.86% |
| 2009 | 422.8 Million USD | -0.54% |
| 2008 | 425.1 Million USD | 148.11% |
| 2007 | 171.33 Million USD | 27.38% |
| 2006 | 134.5 Million USD | 39.62% |
| 2005 | 96.33 Million USD | -10.59% |
| 2004 | 107.74 Million USD | -2.09% |
| 2003 | 110.05 Million USD | 62.54% |
| 2002 | 67.7 Million USD | 42.45% |
| 2001 | 47.53 Million USD | 29.23% |
| 2000 | 36.78 Million USD | 44.56% |
| 1999 | 25.44 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.22 Billion USD | 3.78% |
| 2024 Q1 | 1.06 Billion USD | 9.52% |
| 2024 Q2 | 1.17 Billion USD | 10.88% |
| 2023 Q2 | 914.6 Million USD | 6.5% |
| 2023 FY | 968.3 Million USD | 20.48% |
| 2023 Q1 | 858.8 Million USD | 6.86% |
| 2023 Q3 | 916 Million USD | 0.15% |
| 2023 Q4 | 968.3 Million USD | 5.71% |
| 2022 Q4 | 803.7 Million USD | 7.23% |
| 2022 FY | 803.7 Million USD | 13.18% |
| 2022 Q1 | 739.9 Million USD | 4.2% |
| 2022 Q2 | 759 Million USD | 2.58% |
| 2022 Q3 | 749.5 Million USD | -1.25% |
| 2021 Q4 | 710.1 Million USD | -3.1% |
| 2021 FY | 710.1 Million USD | 2.57% |
| 2021 Q2 | 730.2 Million USD | 4.21% |
| 2021 Q3 | 732.8 Million USD | 0.36% |
| 2021 Q1 | 700.7 Million USD | 1.21% |
| 2020 Q2 | 665.4 Million USD | 6.38% |
| 2020 Q1 | 625.5 Million USD | 8.37% |
| 2020 Q3 | 695.9 Million USD | 4.58% |
| 2020 Q4 | 692.3 Million USD | -0.52% |
| 2020 FY | 692.3 Million USD | 19.94% |
| 2019 Q1 | 541.8 Million USD | 6.32% |
| 2019 Q4 | 577.2 Million USD | -1.62% |
| 2019 Q3 | 586.7 Million USD | -1.33% |
| 2019 FY | 577.2 Million USD | 13.27% |
| 2019 Q2 | 594.6 Million USD | 9.75% |
| 2018 FY | 509.6 Million USD | 4.81% |
| 2018 Q2 | 509.4 Million USD | -1.66% |
| 2018 Q3 | 518.6 Million USD | 1.81% |
| 2018 Q4 | 509.6 Million USD | -1.74% |
| 2018 Q1 | 518 Million USD | 6.54% |
| 2017 Q3 | 515.3 Million USD | 2.02% |
| 2017 FY | 486.2 Million USD | 10.4% |
| 2017 Q4 | 486.2 Million USD | -5.65% |
| 2017 Q1 | 476.4 Million USD | 8.17% |
| 2017 Q2 | 505.1 Million USD | 6.02% |
| 2016 FY | 440.4 Million USD | 4.36% |
| 2016 Q2 | 471 Million USD | 2.37% |
| 2016 Q3 | 483.1 Million USD | 2.57% |
| 2016 Q1 | 460.1 Million USD | 9.03% |
| 2016 Q4 | 440.4 Million USD | -8.84% |
| 2015 Q2 | 486.3 Million USD | 2.62% |
| 2015 Q4 | 422 Million USD | -11.77% |
| 2015 Q3 | 478.3 Million USD | -1.65% |
| 2015 FY | 422 Million USD | -11.6% |
| 2015 Q1 | 473.9 Million USD | -0.73% |
| 2014 Q2 | 612.1 Million USD | -1.35% |
| 2014 Q4 | 477.4 Million USD | -15.77% |
| 2014 Q3 | 566.8 Million USD | -7.4% |
| 2014 Q1 | 620.5 Million USD | 5.21% |
| 2014 FY | 477.4 Million USD | -19.06% |
| 2013 Q2 | 601.8 Million USD | -3.2% |
| 2013 Q3 | 632 Million USD | 5.02% |
| 2013 FY | 589.8 Million USD | -3.55% |
| 2013 Q1 | 621.7 Million USD | 1.67% |
| 2013 Q4 | 589.8 Million USD | -6.68% |
| 2012 Q3 | 632.8 Million USD | 2.02% |
| 2012 FY | 611.5 Million USD | 6.13% |
| 2012 Q2 | 620.3 Million USD | -4.27% |
| 2012 Q4 | 611.5 Million USD | -3.37% |
| 2012 Q1 | 648 Million USD | 12.46% |
| 2011 FY | 576.2 Million USD | 12.76% |
| 2011 Q3 | 601.4 Million USD | -2.8% |
| 2011 Q2 | 618.7 Million USD | 8.24% |
| 2011 Q1 | 571.6 Million USD | 11.86% |
| 2011 Q4 | 576.2 Million USD | -4.19% |
| 2010 Q1 | 431.2 Million USD | 1.99% |
| 2010 FY | 511 Million USD | 20.86% |
| 2010 Q4 | 511 Million USD | 4.76% |
| 2010 Q3 | 487.8 Million USD | 14.91% |
| 2010 Q2 | 424.5 Million USD | -1.55% |
| 2009 Q1 | 420.4 Million USD | -1.11% |
| 2009 Q4 | 422.8 Million USD | -4.69% |
| 2009 Q3 | 443.6 Million USD | 1.65% |
| 2009 FY | 422.8 Million USD | -0.54% |
| 2009 Q2 | 436.4 Million USD | 3.81% |
| 2008 Q1 | 511.59 Million USD | 198.6% |
| 2008 Q3 | 456.81 Million USD | -6.3% |
| 2008 Q4 | 425.1 Million USD | -6.94% |
| 2008 Q2 | 487.5 Million USD | -4.71% |
| 2008 FY | 425.1 Million USD | 148.11% |
| 2007 Q3 | 184.24 Million USD | 8.45% |
| 2007 Q2 | 169.89 Million USD | 7.79% |
| 2007 FY | 171.33 Million USD | 27.38% |
| 2007 Q1 | 157.61 Million USD | 17.18% |
| 2007 Q4 | 171.33 Million USD | -7.01% |
| 2006 FY | 134.5 Million USD | 39.62% |
| 2006 Q4 | 134.5 Million USD | 0.87% |
| 2006 Q3 | 133.34 Million USD | 29.24% |
| 2006 Q2 | 103.17 Million USD | 1.58% |
| 2006 Q1 | 101.56 Million USD | 5.44% |
| 2005 Q1 | 103.44 Million USD | -3.99% |
| 2005 Q2 | 98.35 Million USD | -4.92% |
| 2005 FY | 96.33 Million USD | -10.59% |
| 2005 Q4 | 96.33 Million USD | -3.0% |
| 2005 Q3 | 99.3 Million USD | 0.97% |
| 2004 FY | 107.74 Million USD | -2.09% |
| 2004 Q1 | 107.01 Million USD | -2.76% |
| 2004 Q2 | 105.24 Million USD | -1.65% |
| 2004 Q3 | 106.78 Million USD | 1.47% |
| 2004 Q4 | 107.74 Million USD | 0.9% |
| 2003 Q1 | 69.56 Million USD | 2.74% |
| 2003 Q4 | 110.05 Million USD | 1.52% |
| 2003 Q3 | 108.4 Million USD | 49.31% |
| 2003 Q2 | 72.6 Million USD | 4.37% |
| 2003 FY | 110.05 Million USD | 62.54% |
| 2002 Q2 | 56.99 Million USD | 9.88% |
| 2002 Q1 | 51.86 Million USD | 9.12% |
| 2002 FY | 67.7 Million USD | 42.45% |
| 2002 Q4 | 67.7 Million USD | 16.49% |
| 2002 Q3 | 58.12 Million USD | 1.99% |
| 2001 Q3 | 46.67 Million USD | 5.96% |
| 2001 FY | 47.53 Million USD | 29.23% |
| 2001 Q4 | 47.53 Million USD | 1.84% |
| 2001 Q2 | 44.04 Million USD | 0.17% |
| 2001 Q1 | 43.96 Million USD | 19.54% |
| 2000 Q4 | 36.78 Million USD | 17.32% |
| 2000 Q1 | 31.32 Million USD | 0.0% |
| 2000 FY | 36.78 Million USD | 44.56% |
| 2000 Q2 | 32.16 Million USD | 2.7% |
| 2000 Q3 | 31.35 Million USD | -2.53% |
| 1999 FY | 25.44 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -29153.776% |
| BrainsWay Ltd. | 3.71 Million USD | -25950.578% |
| Cerus Corporation | 39.86 Million USD | -2328.765% |
| Envoy Medical, Inc. | 1.4 Million USD | -68867.236% |
| electroCore, Inc. | 2.16 Million USD | -44728.704% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -211781.838% |
| IceCure Medical Ltd | 2.27 Million USD | -42462.637% |
| Inogen, Inc. | 21.84 Million USD | -4333.608% |
| OrthoPediatrics Corp. | 105.85 Million USD | -814.776% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -348209.353% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -96829999900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -7818.064% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -55978.523% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -618938.486% |
| Orthofix Medical Inc. | 222.16 Million USD | -335.845% |
| PAVmed Inc | 1.01 Million USD | -95111.5% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -4750.959% |
| RxSight, Inc. | 17.42 Million USD | -5458.234% |
| Sight Sciences, Inc. | 7.84 Million USD | -12236.603% |
| SI-BONE, Inc. | 20.24 Million USD | -4681.965% |
| TELA Bio, Inc. | 13.16 Million USD | -7256.785% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -3210.993% |
| Vivos Therapeutics, Inc. | 1.00 USD | -96829999900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -22534.409% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -420900.0% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -40999.321% |
| CVRx, Inc. | 10.98 Million USD | -8716.353% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -248133.678% |
| Bioventus Inc. | 91.33 Million USD | -960.186% |
| Venus Concept Inc. | 28.67 Million USD | -3276.691% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -37947.151% |
| LivaNova PLC | 147.88 Million USD | -554.757% |
| 908 Devices Inc. | 14.93 Million USD | -6382.126% |
| Alphatec Holdings, Inc. | 136.84 Million USD | -607.604% |
| Nemaura Medical Inc. | 1.75 Million USD | -55078.442% |
| NeuroPace, Inc. | 11.21 Million USD | -8534.742% |
| LENSAR, Inc. | 15.68 Million USD | -6071.84% |
| Apyx Medical Corporation | 9.92 Million USD | -9658.138% |
| Cutera, Inc. | 72.1 Million USD | -1242.977% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -36125.215% |
| BioSig Technologies, Inc. | -103 Thousand USD | 940197.087% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -1987.483% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -12139.919% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | -148.532% |
| Axonics, Inc. | 79.94 Million USD | -1111.283% |
| Outset Medical, Inc. | 49.21 Million USD | -1867.49% |
| IRIDEX Corporation | 9.9 Million USD | -9674.884% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -2335.607% |
| IRadimed Corporation | 12.82 Million USD | -7452.339% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -127982.011% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -365977.268% |
| Telesis Bio, Inc. | 4.02 Million USD | -23957.143% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -20930.245% |
| Varex Imaging Corporation | 277.5 Million USD | -248.937% |
| Quipt Home Medical Corp. | 18.32 Million USD | -5183.823% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -5683.313% |
| Dynatronics Corporation | 5.59 Million USD | -17209.698% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -25783.454% |
| Semler Scientific, Inc. | 445 Thousand USD | -217495.506% |
| InMode Ltd. | 45.09 Million USD | -2047.245% |
| Cytosorbents Corporation | 3.68 Million USD | -26211.578% |
| DexCom, Inc. | 559.6 Million USD | -73.034% |
| Align Technology, Inc. | 296.9 Million USD | -226.135% |
| Viveve Medical, Inc. | 1.47 Million USD | -65681.25% |
| ZimVie Inc. | 79.6 Million USD | -1116.457% |
| Movano Inc. | 1.51 Million USD | -63898.678% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -1490.584% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -618938.486% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | -513.093% |
| Profound Medical Corp. | 6.95 Million USD | -13825.878% |
| Insulet Corporation | 402.6 Million USD | -140.512% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -6425.372% |
| iCAD, Inc. | 917 Thousand USD | -105494.329% |
| Nuwellis, Inc. | 1.99 Million USD | -48387.732% |
| Biotricity, Inc. | 1.87 Million USD | -51421.707% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -6829.793% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -45878.158% |
| PAVmed Inc. | 1.01 Million USD | -95111.5% |
| BIOLASE, Inc. | 11.43 Million USD | -8369.343% |
| Beyond Air, Inc. | 2.12 Million USD | -45424.213% |
| FONAR Corporation | 2.71 Million USD | -35559.033% |
| AxoGen, Inc. | 23.02 Million USD | -4106.342% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -4198.397% |
| Inari Medical, Inc. | 42.9 Million USD | -2157.11% |
| UFP Technologies, Inc. | 70.19 Million USD | -1279.522% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -153798.97% |
| Tenon Medical, Inc. | 554 Thousand USD | -174683.394% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -58065.763% |
| AdaptHealth Corp. | 113.64 Million USD | -752.062% |
| Sintx Technologies, Inc. | 888 Thousand USD | -108942.793% |
| NanoVibronix, Inc. | 2.73 Million USD | -35342.899% |
| Quanterix Corporation | 22.36 Million USD | -4229.533% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -6421.856% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -1608.483% |
| TransMedics Group, Inc. | 44.23 Million USD | -2088.991% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -17028.958% |
| NeuroMetrix, Inc. | 1.55 Million USD | -61993.28% |
| Hyperfine, Inc. | 6.58 Million USD | -14611.334% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | -1111.299% |
| Biomerica, Inc. | 2.37 Million USD | -40653.367% |
| Bone Biologics Corporation | -328.84 Thousand USD | 294555.73% |
| AVITA Medical, Inc. | 3.12 Million USD | -30921.217% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -3141.063% |